Standard treatment for people who have suffered a stroke or mini-stroke (transient ischaemic attack, or TIA) usually includes taking blood pressure lowering medication, cholesterol lowering medication and aspirin, taken separately. In this trial, these have been combined in to one capsule called Trinomia. The aim of these treatments is to reduce the chance of having another stroke.
We are interested in ‘combined’ pills such as Trinomia as they reduce the number of pills patients need to take, and they ensure that the multiple medicines needed to lower the risk of having another stroke are provided. They may also reduce the costs associated with prescribing and patient monitoring.
We want to find out if taking the Trinomia capsule is at least as good as standard treatment. We plan to include around 1200 people from 100 GP surgeries in the UK.
If you are interested in finding out more about the trial, please use the ‘for trial participants’ menu above to find out more about the trial, including who is eligible to take part, what taking part involves, what happens at the trial visits, and more information about Trinomia. There is also a page with links to the participant information sheets for trial participants which you can download and print to read in your own time, if you prefer. If you have any questions, you can get in touch with the trial team here.